For the study, the investigators examined the health of 2,770 children from birth to age 16. Kids with IBS at age 16 were more likely to have had asthma at age 12 (about 11% versus 7%).
In addition, the researchers found that 16-year-olds with IBS were more likely to have had food hypersensitivity at age 12 (41% versus 29%).
Asthma, food hypersensitivity and eczema (a condition that makes your skin red and itchy) were all associated with an increased risk of concurrent IBS at age 16, the findings showed.
“The associations found in this large study suggest there’s a shared pathophysiology between common allergy-related diseases and adolescent irritable bowel syndrome,” said study leader Jessica Sjölund, of the Institute of Medicine at the University of Gothenburg, in Sweden.
Sjölund noted that previous studies on allergy-related diseases and IBS have been contradictory.
These new findings could lead to development of new treatments for adolescent IBS, targeting processes of low-grade inflammation seen in the allergy-related diseases, she said.
The study findings were scheduled for presentation Monday at a United European Gastroenterology virtual meeting. Research presented at meetings should be considered preliminary until published in a peer-reviewed journal.
IBS affects more than one in 10 people and is the most common functional gastrointestinal disorder, the study authors noted in a meeting news release. It can cause abdominal cramps, bloating, diarrhea and constipation, and can be extremely disabling for patients.
Hans Törnblom is a leading IBS expert in Europe who was involved in the research. He said, “Even though functional gastrointestinal disorders are common, many patients are, unfortunately, negatively stigmatized and labeled. The fact that many IBS sufferers do not seek medical advice should be of great concern.”
© 2020 HealthDay. All rights reserved.
Posted: October 2020
- WHO counts 18 million virus cases last week as omicron slows - January 19, 2022
- Diet & Nutrition plan for a Head and Neck Cancer Patient - January 17, 2022
- COVID-19: HC urged to direct govt to give road map to vaccinate kids of 12 yrs and below - January 17, 2022
- 2,500 Delhi Police personnel infected, 767 cured of Covid since January 1 - January 17, 2022
- AstraZeneca vaccine trials show 3 doses give good protection against Omicron: Serum CEO - January 13, 2022
- Omicron Alert: FFD Launches Free Helpline For Diabetics - January 13, 2022
- Alkem Laboratories to Launch State of the Art Technology for Diabetic Foot Ulcer Management - January 13, 2022
- Metropolis Healthcare launches the 3rd edition of MedEngage Scholarship program to support aspiring young medical students - January 12, 2022
- Infections could surge 6 times higher due to omicron: Russia - January 12, 2022
- Makar Sankranti: Odisha bans religious gatherings; no holy dip at Haridwar - January 12, 2022